A novel mechanism of action of atorvastatin against cardiovascular risk: A commentary on "Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins"

被引：5

作者：

Emanuele, Enzo ^{[1
]}

Geroldi, Diego ^{[1
]}

机构：

[1] Univ Pavia, Interdept Ctr Res Mol Med, I-27100 Pavia, Italy

来源：

FREE RADICAL BIOLOGY AND MEDICINE | 2007年 / 43卷 / 09期

关键词：

D O I：

10.1016/j.freeradbiomed.2007.07.008

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1231 / 1232

页数：2

共 14 条

[1] Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review [J].

Balk, EM ;

Lau, J ;

Goudas, LC ;

Jordan, HS ;

Kupelnick, B ;

Kim, LU ;

Karas, RH .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) :670-682

[2] Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein [J].

Basta, Giuseppina ;

Sironi, Anna Maria ;

Lazzerini, Guido ;

Del Turco, Serena ;

Buzzigoli, Emma ;

Casolaro, Arturo ;

Natali, Andrea ;

Ferrannini, Ele ;

Gastaldelli, Amalia .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4628-4634

[3] Suppression of rage as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes [J].

Cuccurullo, Chiara ;

Iezzi, Annalisa ;

Fazia, Maria Luigia ;

De Cesare, Domenico ;

Di Francesco, Andrea ;

Muraro, Raffaella ;

Bei, Roberto ;

Ucchino, Sante ;

Spigonardo, Francesco ;

Chiarelli, Francesco ;

Schmidt, Ann Marie ;

Cuccurullo, Franco ;

Mezzetti, Andrea ;

Cipollone, Francesco .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) :2716-2723

[4] Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia [J].

Emanuele, E ;

D'Angelo, A ;

Tomaino, C ;

Binetti, G ;

Ghidoni, R ;

Politi, P ;

Bernardi, L ;

Maletta, R ;

Bruni, AC ;

Geroldi, D .

ARCHIVES OF NEUROLOGY, 2005, 62 (11) :1734-1736

[5] Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men [J].

Falcone, C ;

Emanuele, E ;

D'Angelo, A ;

Buzzi, MP ;

Belvito, C ;

Cuccia, M ;

Geroldi, D .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1032-1037

[6] Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy [J].

Forbes, JM ;

Thorpe, SR ;

Thallas-Bonke, V ;

Pete, J ;

Thomas, MC ;

Deemer, ER ;

Bassal, S ;

El-Osta, A ;

Long, DM ;

Panagiotopoulos, S ;

Jerums, G ;

Osicka, TM ;

Cooper, ME .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08) :2363-2372

[7] Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension [J].

Geroldi, D ;

Falcone, C ;

Emanuele, E ;

D'Angelo, A ;

Calcagnino, M ;

Buzzi, MP ;

Scioli, GA ;

Fogari, R .

JOURNAL OF HYPERTENSION, 2005, 23 (09) :1725-1729

[8] Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target [J].

Geroldi, Diego ;

Falcone, Colomba ;

Emanuele, Enzo .

CURRENT MEDICINAL CHEMISTRY, 2006, 13 (17) :1971-1978

[9] RAGE axis - Animal models and novel insights into the vascular complications of diabetes [J].

Naka, Y ;

Bucciarelli, LG ;

Wendt, T ;

Lee, LK ;

Rong, LL ;

Ramasamy, R ;

Yan, SF ;

Schmidt, AM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1342-1349

[10] Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin [J].

Okamoto, T ;

Yamagishi, S ;

Inagaki, Y ;

Amano, S ;

Koga, K ;

Abe, R ;

Takeuchi, M ;

Ohno, S ;

Yoshimura, A ;

Makita, T .

FASEB JOURNAL, 2002, 16 (12) :1928-+

← 1 2 →